Q. What is the name of the biosimilar antidiabetic drug recently launched by Glenmark in the Indian market? Answer:
Lirafit
Notes: Glenmark pharmaceuticals launched Lirafit, a biosimilar of popular antidiabetic medicine Liraglutide, in India priced nearly 70% cheaper to make the therapy more affordable for diabetic patients in the country.
